Avalanche Biotechnologies Inc Stock Nasdaq
Equities
US05337G1076
Biotechnology & Medical Research
Sales 2024 * | 239K 326K | Sales 2025 * | 8.8M 12.02M | Capitalization | 158M 215M |
---|---|---|---|---|---|
Net income 2024 * | -119M -163M | Net income 2025 * | -147M -201M | EV / Sales 2024 * | 37.7 x |
Net cash position 2024 * | 149M 203M | Net cash position 2025 * | 136M 185M | EV / Sales 2025 * | 2.53 x |
P/E ratio 2024 * |
-1.21
x | P/E ratio 2025 * |
-1.33
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.21% |
Latest transcript on Avalanche Biotechnologies Inc
Managers | Title | Age | Since |
---|---|---|---|
Laurent Fischer
CEO | Chief Executive Officer | 60 | 20-06-14 |
Linda Rubinstein
DFI | Director of Finance/CFO | 58 | 22-12-11 |
Bill Tan
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Whitcup
BRD | Director/Board Member | 64 | 20-04-15 |
Clarence Machado
CHM | Chairman | 60 | 17-03-13 |
Laurent Fischer
CEO | Chief Executive Officer | 60 | 20-06-14 |
1st Jan change | Capi. | |
---|---|---|
+12.30% | 116B | |
+12.15% | 106B | |
-8.14% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-15.33% | 16.33B | |
+5.80% | 14.14B | |
+28.03% | 12.02B |